Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-06

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to investigate cardiac function in patients with cirrhosis in the acute setting. Acute decompensation and acute-on-chronic liver failure are major events in the life of a patient as they herald disease progression and negative prognosis. Cardiocirculatory function will be assessed by serial assessments in patients admitted for acute decompensation of cirrhosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ventriculo-arterial Coupling in Cirrhotics

NCT03948659

Cirrhosis

COMPLETED

Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment

NCT03443934

Portal Hypertension Liver Diseases Liver Cirrhoses +1 more

COMPLETED

Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

NCT05213598

Congenital Heart Disease

RECRUITING

Acute-On-Chronic Liver Failure In Cirrhotic Patients

NCT04790435

Cirrhosis, Liver

COMPLETED

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

NCT06855056

Liver Cirrhosis Decompensated Cirrhosis of Liver

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this project we aim to investigate the dynamic role of cardiac function in the short-term evolution of patients with AD of cirrhosis through noninvasive and accessible tests and validate prognostic imaging and serum biomarkers. The main objectives are:

1. To describe changes and evolution of cardiac function in AD of cirrhosis
2. To investigate associations between echocardiographic parameters and serum biomarkers
3. To investigate the association between ACLF and cardiac dysfunction
4. To assess the short-term prognostic impact of cardiac function in AD and ACLF;
5. To evaluate the added predictive value of cardiac markers to current scores (CLIF-C).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cirrhosis Acute Liver Failure Cardiomyopathies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* proven cirrhosis with acute decompensation

Exclusion Criteria

* screening after \> 72 hours from admission
* previous severe cardiac conditions (e.g. ischemic heart disease, atrial fibrillation, congestive heart failure, ICD)
* concomitant severe disease (e.g. active neoplasia, severe COPD, etc)
* lack of informed consent
* intubated/ comatose patient

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No